July 10, 2009 | by Jan F. Dudt | Topic: Faith & Society Print
We hear a lot about stem cells, which are front-and-center as a major policy debate in America, one that involves science, medicine, ethics, politics, and much more.
What are the issues? Whats at stake? What are embryonic and non-embryonic stem cells? What are the crucial differences and distinctions we need to make as a society and citizenry?
Stem-cell technologies are some of the newest and fastest developing biotechnologies. Typically, along with genetic engineering and cloning, these technologies constitute the kind of 21st century advances that make this the century of Biology.
A stem cell is a type of cell that is nonspecific in its function; in contrast, for instance, to a heart or brain cell, which is functionally specific. There are two major sources of stem cells: embryonic stem cells and non-embryonic stem cells. Embryonic stem cells are obtained from 5- to 12-day old embryos. Although removal of a stem cell from an embryo kills the embryo, the stem cells are valued for their potential to produce any type of cell. That is, they have high plasticity. Conversely, non-embryonic stem cells are found in large quantities in placenta, umbilical cord blood, amniotic fluid, and in essentially all adult organs or tissues, including bone marrow, fat, kidney, liver, pancreases, intestines, breast, lung, etc. Any of these non-embryonic stem cells have ample plasticity and can give rise to nearly any type of cells, including heart, liver, lung, muscle, etc.
Thus, the heart of the stem-cell controversy centers on the aforementioned fact that the extraction of stem cells from 5- to 12-day embryos kills the embryo. But thats not the only issue: In addition, stem cells derived from an embryonic human may, in turn, reject the person who receives them. This situation is called graft-versus-host-disease (GVHD). The problem can be avoided by producing an embryonic clone of the person needing the stem cells. However, the procedure produces an embryo that is indistinguishable from an embryo from a fertilized egg. This embryonic clone would be destroyed during the stem-cell harvesting required by the therapy. This type of cloning is called therapeutic cloning, since the production of a human baby is not the goal. (Reproductive cloning, producing a cloned human baby, has been universally outlawed.)
Another problem is that the embryonic stem cells can unpredictably cause cancer in the treated patient.
On the other hand, newly developed treatments associated with non-embryonic (adult) stem cells are way ahead of any hoped-for treatments associated with embryonic stem cells. Recent non-embryonic stem-cell therapies include treatments for non-healing bone breaks, healing damaged hearts, regenerating damaged muscles, correcting scoliosis, regenerating knee cartilage, treating thalassemia, osteoarthritis, diabetes, lupus, multiple sclerosis, spinal chord and nerve damage. Treatments to heal conditions associated with almost any organ or tissue are in view. These advances cast serious doubt on the need to develop embryonic stem-cell therapies, especially since embryonic technologies are morally objectionable, given that they require the death of the human embryo.
The use of ones own adult stem cells (autologous stem-cell transplant) is a way to avoid the problems of rejection and of killing human embryos. Also, certain types of adult stem cells (mesenchymal cells) can be harvested from anyone and changed in the lab (transdifferentiated) into a desired cell. In both of these stem-cell applications there are no adverse effects to the donor of the adult stem cells. The non-embryonic stem cells are safely harvested, purified from other cells and/or expanded in culture, and introduced into the patient without rejection. In another process, virtually any adult cell can be harvested from ones own body and treated to become cells capable of producing the needed cell type (induced pluripotent stem cells or iPS). These cells can also be cultured in the lab, and reintroduced into the patient. All of these sources of adult stem cells avoid the problem of having to use patented embryonic stem-cell lines that would be less available to the public.
And yet, the reputed plasticity of the embryonic stem cells continues to make the prospects of doing research on human embryos attractive to researchers who are uninhibited by the prospect of killing human embryos.
It is worth pointing out that, in terms of medical applications and treatments, two major facts are usually left out of these discussions: First, non-embryonic stem-cell treatments have been used to treat tens of thousands of patients, and with dramatic benefits. However, embryonic stem cells have not had one clinical trial with humans. Also, it has been clearly demonstrated that non-embryonic stem cells do not produce cancerous tumors in humans. Whether iPS cells share this non-tumorigenic quality is not yet clear. However, iPS cells have all of the medical application value hoped for in embryonic stem cells.
It must be noted that in a field as rapidly moving as stem-cell research, this situation will likely not be current for long. However, the current progress of stem-cell research as of spring 2009 speaks volumes regarding the effectiveness of non-embryonic vs. embryonic stem-cell research. The promises of embryonic stem-cell researchers are wildly overstated. The claims that embryonic stem-cell therapies will be available in five to 10 years rings hollow.
Aside from these scientific considerations, there are moral-religious matters of obvious concerns to Christians:
Christians committed to the sanctity of human life should look with favor on technologies that preserve and/or improve human life. Consequently, non-embryonic stem-cell advances should be embraced when they: 1) respect the consent and preserve the dignity of the stem-cell donors, 2) enhance the health of the stem-cell recipient, and 3) protect human life at every stage of development. Embryonic stem-cell harvesting remains problematic because the procedure destroys the smallest and most helpless members of the human family: embryos.
In truth, embryonic stem-cell use is being trumped by successful and surprising advances in adult and other non-embryonic stem-cell research. These advances protect the dignity of the donor and recipient while recognizing the value of all humans, regardless of their stage of life, from conception through old age. Hence, all frozen human embryos should be given a chance to be born, not given over to researchers to be destroyed for the sake of a research project.
Dr. Jan Dudt is a professor of biology at Grove City College and fellow for medical ethics with The Center for Vision & Values. He teaches as part of colleges required core course Studies in Science, Faith and Technology wherein students, among other things, study all of the major origins theories and are asked to measure them in the light of biblical authority.
All posts by Jan F. Dudt | High resolution photos
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To... - Azizsalon News - May 21st, 2020
- Georgetown student takes Islamic bioethics research at QF to Washington and wins - Gulf Times - May 21st, 2020
- Dose-dependent functions of SWI/SNF BAF in permitting and inhibiting cell proliferation in vivo - Science Advances - May 21st, 2020
- Human Embryonic Stem Cells (HESC) Market to witness an impressive growth during - News by aeresearch - May 20th, 2020
- Qatar- Georgetown student takes Islamic bioethics research at QF to Washington and wins - MENAFN.COM - May 15th, 2020
- Millions of Human Cells Have Been Grown Inside Mice Embryos - Newsweek - May 14th, 2020
- AgeX Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update - Business Wire - May 14th, 2020
- Human Embryonic Stem Cells (HESC) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty - May 14th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 14th, 2020
- 2025 Projections: Cell Freezing Media for Cell Therapy Market Report by Type, Application and Regional Outlook - AlgosOnline - May 14th, 2020
- Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS) - The... - May 14th, 2020
- Strides in Medical Tourism Market Key Driver of Low-cost Patient Care in Globalized Healthcare Systems, Notes TMR - Stockhouse - May 14th, 2020
- Uses and Abuses of Scientific Consensus - National Review - May 13th, 2020
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy - Business Wire - May 13th, 2020
- COVID-19 Impact on STEM CELL THERAPY MARKET 2020 TO 2027-EXPANDING WORLDWIDE WITH TOP PLAYERS FUTURE BUSINESS SCOPE AND INVESTMENT ANALYSIS REPORT -... - May 13th, 2020
- Human Embryonic Stem Cells (HESC) Market 2020 | Growth Drivers, Challenges, Trends, Market Dynamics and Forecast to 2026 - Cole of Duty - May 10th, 2020
- Louis Bacon Is Having The Time Of His Life - Dealbreaker - May 10th, 2020
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy - Yahoo Finance - May 10th, 2020
- Human Embryonic Stem Cells, Germ Cells, and Cell-Derived ... - May 7th, 2020
- Inside the twisted world of 'rapist' designer Peter Nygard: book - The Loppy - May 4th, 2020
- Lack of investment is the biggest challenge in stem cell research - Express Healthcare - May 2nd, 2020
- AgeX Therapeutics: Revolutionary Potential But Extremely Early - Seeking Alpha - April 30th, 2020
- Human Embryonic Stem Cells (HESC) Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald - April 27th, 2020
- Role of MyHC-embryonic protein in muscle development and disease - Tech Explorist - April 27th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 26th, 2020
- Sustainably Yours: The importance of understanding and trusting in Science - The Phuket News - April 26th, 2020
- Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify's iPSC- and ESC-derived regulatory T cells - SelectScience - April 24th, 2020
- Stem Cell Therapy Market Research Outlook, Recent Trends and Growth Forecast 2020-2025 - Cole of Duty - April 24th, 2020
- Mogrify and Sangamo in license agreement for 'off-the-shelf' CAR-Treg - BioPharma-Reporter.com - April 23rd, 2020
- Lozier praises promising, and ethical, blindness study - OneNewsNow - April 23rd, 2020
- A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer - Science Advances - April 23rd, 2020
- PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis - Science Advances - April 21st, 2020
- Cyborg computer chips will get their brain from human neurons - SYFY WIRE - April 11th, 2020
- Stem Cells Market Expected to Boost the Global Industry Growth in the Near Future - Germany English News - April 11th, 2020
- Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance - Science Advances - April 11th, 2020
- Turning Back the Clock on Aging Cells - The New York Times - March 31st, 2020
- A New Way to Study HIV's Impact on the Brain - Global Health News Wire - March 31st, 2020
- Human Embryonic Stem Cell Market Analysis and Forecasts to 2027 By Recent Trends, Developments In Manufacturing Technology And Regional Growth... - March 31st, 2020
- Laboratory model looking at how a HIV infection impacts the brain - Health Europa - March 31st, 2020
- Cell Banking Outsourcing Market With Economic Growth And Five Forces Analysis By 2021 - Lake Shore Gazette - March 30th, 2020
- Global Human Embryonic Stem Cells Market Provides an In-Depth Insight of Sales Analysis, Growth Forecast and Upcoming Trends Opportunities by Types... - March 26th, 2020
- PD-1 Blocker Safe in Childhood Cancers. But Does It Work? - MedPage Today - March 19th, 2020
- YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma - Science Advances - March 19th, 2020
- Can hybrid embryos save the white rhinos from extinction? - Science 101 - March 17th, 2020
- Autologous Stem Cell Based Therapies Market 2020: Potential Growth, Challenges, Attractive Valuation | Key Players: Anterogen, Holostem Advanced... - March 17th, 2020
- Worldwide Cell Therapy Market Projections to 2028 - The Largest Expansion Will Be in Diseases of the Central Nervous System, Cancer and Cardiovascular... - March 15th, 2020
- 22.5% Growth Rate for Synthetic Stem Cells Market by 2028 | Overview, Top Technologies, Key Insights and Company Profiles - News Times - March 15th, 2020
- Single-Cell Analysis of Ovarian Cortex Fails to Find Stem Cells - The Scientist - March 7th, 2020
- Organoids, iPSCs, and advanced cell models: Advancing discovery from basic research to drug discovery - Science Magazine - March 2nd, 2020
- Stem Cell Therapy Market Opportunity Analysis and Industry Forecast up to 2017 2025 - Jewish Life News - March 2nd, 2020
- The very interesting life of the Hydractinia - Jill Lopez - February 28th, 2020
- Intrinsic disorder controls two functionally distinct dimers of the master transcription factor PU.1 - Science Advances - February 22nd, 2020
- Stem Cell Therapy Market: Business Opportunities, Current Trends and Industry Analysis by 2018 2028 - Instant Tech News - February 21st, 2020
- Anatomy of a grant: Ashley Kramer's yearlong journey to finding her doctoral thesis - The South End - February 21st, 2020
- The Challenge of Bioethics to Decision-Making in the UK - Westminster Abbey - February 21st, 2020
- The 411 on Stem Cells: What They Are and Why It's Important to Be Educated - Legal Examiner - February 17th, 2020
- Will Cultured Meat Soon Be A Common Sight In Supermarkets Across The Globe? - Forbes - February 17th, 2020
- Genetic Secrets of How a Strange Marine Animal Produces Unlimited Eggs and Sperm Over Its Lifetime - SciTechDaily - February 15th, 2020
- Stem Cells Market Report by Manufacturers, Regions, Type and Application Forecast 2020-2025, Trends, Proportions, Share and SWOT. - Chronicle 99 - February 15th, 2020
- Embryonic Stem Cells - February 11th, 2020
- 3. Embryonic Stem Cells | Stem Cells and the Future of ... - February 5th, 2020
- Embryonic Stem Cell Fact Sheet - February 5th, 2020
- Embryonic Stem Cell Research Pros and Cons - Biology Wise - February 5th, 2020
- Early onset Parkinsons might begin in the womb: Prevention a possibility - The New Daily - February 1st, 2020
- How does the embryo make all its parts at just the right moments? - Knowable Magazine - January 31st, 2020
- Biobanking Market to Witness an Outstanding Growth During 2019-2030 :Thermo Fisher Scientific Inc., PHC Holdings Corporation, QIAGEN NV - Media... - January 31st, 2020
- What are Progenitor Cells? Exploring Neural, Myeloid and Hematopoietic Progenitor Cells - Technology Networks - January 29th, 2020
- Lab-Grown Heart Muscles Have Been Transplanted Into a Human For The First Time - ScienceAlert - January 29th, 2020
- Antibodies recognizing the C terminus of PP2A catalytic subunit are unsuitable for evaluating PP2A activity and holoenzyme composition - Science - January 29th, 2020
- Comprehensive Research on Human Embryonic Stem Cells (HESC) Market Report 2026 | Astellas Pharma Inc/ Ocata Therapeutics ,STEMCELL Technologies... - January 26th, 2020
- Stem Cell Therapy Market Anticipated to Grow at a Significant Pace by 2020 - The Trusted Chronicle - January 26th, 2020
- What I Learned About Marriage as a Survivor of Abuse - SWAAY - January 26th, 2020
- Stem Cell Therapy Market Current Trends and Future Growth Dagoretti News - Dagoretti News - January 22nd, 2020
- Memphis Meats raises $161m to build its cell-based meat platform: 'We have a pretty clear path to bringing prices down to cost parity' -... - January 22nd, 2020
- Stem Cell Assay Market Predicted to Accelerate the Growth by 2017-2025 Dagoretti News - Dagoretti News - January 17th, 2020
- Team builds the 1st living robots - EarthSky - January 17th, 2020
- Team Builds the First Living Robots - Newswise - January 17th, 2020
- The 'xenobot' is the worlds newest robot and it's made from living animal cells - The Loop - January 17th, 2020
- Scientists Have Built The First-Ever Robots Constructed Entirely Out of Living Cells - ScienceAlert - January 14th, 2020
- Scientists Assemble Frog Stem Cells Into First 'Living Machines' - Smithsonian.com - January 13th, 2020